Xie Jigang 谢纪刚

谢纪刚先生:1973年1月出生,中国国籍,无境外永久居留权,北京交通大学工学博士、应用经济学博士后,现任北京交通大学副教授、硕士生导师,华北制药股份有限公司独立董事,中材节能股份有限公司独立董事,江苏博生医用新材料股份有限公司独立董事。自2007年以来从事企业并购方面的相关研究,研究方向主要为并购市场、并购估值、并购风险管理、并购会计与审计等,主持及参与了企业并购、内部控制、合并会计、并购后评价等数十项课题,对上市公司控制权市场、财务信息披露及内部控制规范、内部审计领域较为熟悉。

English Translation 英文译文 · Organisation Names in Chinese 机构名称保留中文Mr. Xie Jigang: born in January 1973, Chinese nationality, no overseas permanent residence, 北京交通大学 Doctor of Engineering, postdoctoral in Applied Economics, currently 北京交通大学 Associate Professor, Supervisor of Master's Candidates, 华北制药股份有限公司 (North China Pharmaceutical) Independent Director, 中材节能股份有限公司 (Sinoma Energy Conservation) Independent Director, 江苏博生医用新材料股份有限公司 Independent Director. Since 2007, engaged in research related to corporate mergers and acquisitions, mainly focusing on the M&A market, M&A valuation, M&A risk management, M&A accounting and auditing, etc., has presided over and participated in dozens of topics on corporate mergers and acquisitions, internal control, merger accounting, and post-merger evaluation, and is quite familiar with the listed companies' control rights market, financial information disclosure and internal control standards, and internal audit field.